ATE359797T1 - Pharmazeutische zusammensetzung mit chito- oligomeren - Google Patents

Pharmazeutische zusammensetzung mit chito- oligomeren

Info

Publication number
ATE359797T1
ATE359797T1 AT02777769T AT02777769T ATE359797T1 AT E359797 T1 ATE359797 T1 AT E359797T1 AT 02777769 T AT02777769 T AT 02777769T AT 02777769 T AT02777769 T AT 02777769T AT E359797 T1 ATE359797 T1 AT E359797T1
Authority
AT
Austria
Prior art keywords
oligomers
pharmaceutical composition
composition containing
treatment
chito
Prior art date
Application number
AT02777769T
Other languages
German (de)
English (en)
Inventor
Jon M Einarsson
Johannes Gislason
Martin Peter
Sven Bahrke
Original Assignee
Genis Ehf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genis Ehf filed Critical Genis Ehf
Application granted granted Critical
Publication of ATE359797T1 publication Critical patent/ATE359797T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • A61K31/722Chitin, chitosan
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C08B37/00272-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
    • C08B37/003Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biotechnology (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Genetics & Genomics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
AT02777769T 2001-09-26 2002-09-26 Pharmazeutische zusammensetzung mit chito- oligomeren ATE359797T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IS6085A IS6085A (is) 2001-09-26 2001-09-26 Lyfjablanda með kítósan óligómerum

Publications (1)

Publication Number Publication Date
ATE359797T1 true ATE359797T1 (de) 2007-05-15

Family

ID=36700489

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02777769T ATE359797T1 (de) 2001-09-26 2002-09-26 Pharmazeutische zusammensetzung mit chito- oligomeren

Country Status (13)

Country Link
US (2) US7985741B2 (enExample)
EP (1) EP1435976B1 (enExample)
JP (1) JP4613008B2 (enExample)
KR (1) KR20040062548A (enExample)
AT (1) ATE359797T1 (enExample)
CA (1) CA2507926C (enExample)
DE (1) DE60219653T2 (enExample)
DK (1) DK1435976T3 (enExample)
ES (1) ES2284935T3 (enExample)
IS (2) IS6085A (enExample)
PT (1) PT1435976E (enExample)
SI (1) SI1435976T1 (enExample)
WO (1) WO2003026677A1 (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003054208A2 (en) * 2001-12-13 2003-07-03 Ism Biopolymer Inc. Method of modulating release of saccharides and uses thereof
GB0321996D0 (en) * 2003-09-19 2003-10-22 Novartis Nutrition Ag Organic compounds
EP1670486A4 (en) * 2003-10-01 2009-04-01 Optimer Pharmaceuticals Inc TREATMENT OF A CONDITION IN A MAMMALIAN WITH ADMINISTRATION OF AMINO SUGAR AND USES THEREOF
WO2005051326A2 (en) * 2003-11-24 2005-06-09 Optimer Pharmaceuticals, Inc. Treatment of a condition in a mammal with administration of compounds and methods of use thereof
JP4496375B2 (ja) * 2004-05-21 2010-07-07 国立大学法人鳥取大学 創傷の治療又は処置のための薬剤
JP5632125B2 (ja) * 2005-06-14 2014-11-26 ジェニス イーエイチエフ.Genis ehf. 部分的脱アセチル化キチン誘導体の組成物
US7485718B2 (en) 2005-06-16 2009-02-03 E. I. Du Pont De Nemours And Company Chemical synthesis of low molecular weight polyglucosamines and polygalactosamines
WO2007001282A2 (en) * 2005-06-16 2007-01-04 E.I. Dupont De Nemours And Company Low molecular weight polyglucosamines and polygalactosamines
KR100831335B1 (ko) * 2006-06-22 2008-05-22 부경대학교 산학협력단 인간 피부 섬유아세포에서 메트릭스메탈로프로테이나제-2의 발현 및 활성을 억제시키는키토올리고사카라이드 화합물 및 이를 함유한 메트릭스메탈로프로테이나제-2 억제제
WO2010007631A1 (en) * 2008-07-18 2010-01-21 Genis Ehf. New composition for treating autoimmune disorders
KR20100060634A (ko) * 2008-11-28 2010-06-07 (주)아모레퍼시픽 미토콘드리아 활성화를 위한 조성물
KR101729137B1 (ko) * 2009-07-28 2017-04-26 (주)아모레퍼시픽 키토올리고당을 함유하는 피로회복용 조성물
MX368764B (es) 2011-06-03 2019-10-15 Maguire Abbey Llc Método, composición, y artículos para mejorar la lubricación de articulación.
AR090026A1 (es) 2011-09-08 2014-10-15 Novozymes Bioag As Metodos y composiciones para tratamiento de semillas
EP2748123B1 (en) 2011-09-14 2023-11-08 Novozymes Bioag A/S Use of lipochito-oligosaccharides and/or chito oligosaccharides in combination with phosphate-solubilizing microorganisms to enhance plant growth
UA114299C2 (uk) 2011-09-23 2017-05-25 Новозаймс Біоаг А/С Хітоолігосахариди та способи застосування при стимулюванні росту рослин
MX2014003411A (es) * 2011-09-23 2015-03-19 Novozymes Bioag As Quitooligosacaridos y metodos para el uso en el mejoramiento del crecimiento del maiz.
CN104470550A (zh) 2012-04-23 2015-03-25 杰尼斯公共有限公司 作为骨移植替代物的含有部分脱乙酰壳多糖的自硬化生物活性接合剂组合物
JP6285497B2 (ja) * 2016-06-07 2018-02-28 株式会社エバーライフ 鶏冠抽出物含有経口組成物及び鶏冠抽出物の香味に由来する摂取困難性の改善方法
KR101673368B1 (ko) 2016-07-14 2016-11-08 김기혁 공정가스 반응물의 콜드트랩 장치
WO2023205718A2 (en) * 2022-04-21 2023-10-26 Hassan Ameer E Methods of treating inflammation

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5919122B2 (ja) * 1976-10-12 1984-05-02 味の素株式会社 水溶性部分脱アセチル化キチン及びその製造法
US4532134A (en) * 1981-04-06 1985-07-30 Malette William Graham Method of achieving hemostasis, inhibiting fibroplasia, and promoting tissue regeneration in a tissue wound
JP2527317B2 (ja) * 1986-12-19 1996-08-21 ライオン株式会社 骨疾患治療剤
US6184037B1 (en) * 1996-05-17 2001-02-06 Genemedicine, Inc. Chitosan related compositions and methods for delivery of nucleic acids and oligonucleotides into a cell
DE69733089T2 (de) * 1996-12-13 2005-09-29 Lescarden Inc. Behandlung der osteoarthritis durch verabreichung von poly-n-acetyl-d-glucosamin
JP3062592B2 (ja) * 1997-05-30 2000-07-10 農林水産省食品総合研究所長 2−アセチルアミノ−4−O−(2−アミノ−2−デオキシ−β−D −グルコピラノシル)−2−デオキシ−D −グルコースおよびその塩の製造法
US6492350B2 (en) * 2000-01-27 2002-12-10 Jdc (Hawaii) Inc. Chitin oligosaccharides and/or chitosan oligosaccharides for preventing or treating common cold or treating pain
EP1127574A1 (en) * 2000-02-22 2001-08-29 Food Industry Research and Development Institute Use of chitinous materials for inhibiting cellular nitric oxide production
CA2313836C (en) * 2000-03-15 2009-06-09 Cargill, Incorporated Chitosan and method of preparing chitosan
US20020119949A1 (en) * 2001-02-26 2002-08-29 Asa Hellman Prophylactic teat treatment
JP5632125B2 (ja) 2005-06-14 2014-11-26 ジェニス イーエイチエフ.Genis ehf. 部分的脱アセチル化キチン誘導体の組成物

Also Published As

Publication number Publication date
IS6085A (is) 2003-03-27
ES2284935T3 (es) 2007-11-16
WO2003026677A1 (en) 2003-04-03
SI1435976T1 (sl) 2007-08-31
CA2507926C (en) 2011-12-20
CA2507926A1 (en) 2003-04-03
US20050004073A1 (en) 2005-01-06
IS2783B (is) 2012-05-15
PT1435976E (pt) 2007-06-28
DK1435976T3 (da) 2007-08-27
EP1435976B1 (en) 2007-04-18
US20110257381A1 (en) 2011-10-20
DE60219653D1 (de) 2007-05-31
DE60219653T2 (de) 2008-01-03
KR20040062548A (ko) 2004-07-07
JP4613008B2 (ja) 2011-01-12
IS7193A (is) 2004-03-22
US7985741B2 (en) 2011-07-26
EP1435976A1 (en) 2004-07-14
JP2005507891A (ja) 2005-03-24
US8415326B2 (en) 2013-04-09

Similar Documents

Publication Publication Date Title
ATE359797T1 (de) Pharmazeutische zusammensetzung mit chito- oligomeren
CA2303498A1 (en) Dioxocyclopentyl hydroxamic acids
EP2085780A3 (en) Methods and products related to low molecular weight heparin
EP2497478A3 (en) Oligosaccaride compositions and use thereof in the treatment of infection
BR0204588A (pt) Derivados de n-alquil-adamantil-triazinil-benzamida
ITRM990338A0 (it) Composizione dietetica o farmaceutica utile per la prevenzione o il trattamento dell'iperossaluria.
ATE525076T1 (de) Behandlung von traumatischer synovitis und geschädigtem gelenkknorpel
BG101209A (bg) Хиполипидемични 1,4-бензотиазепин-1,1-диоксиди
SE0102315D0 (sv) Compounds
EA200501700A1 (ru) Применение эффектов глутаминил- и глутаматциклаз
MY140840A (en) Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals
FR2842201B1 (fr) Nouvel oligosaccharide, compositions cosmetiques et/ou dermatologiques en contenant et ses applications
BRPI9914741B1 (pt) n-(2-aril-proprionil)-sulfonamidas, usos e composições farmacêuticas contendo as mesmas.
WO2004105737A3 (en) Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions using various agents
DE60313004D1 (de) Alpha-7-nikotinsäure-rezeptoragonisten und statine in kombination
NO20056161L (no) Formuleringer for behandling av artrittilstander
NO20010940L (no) TAN-1057 derivater
IS6914A (is) 2-þíó-útskiptar imídasólafleiður og notkun þeirraí lyfjaiðnaðinum
TW200510012A (en) Aqua gel comprising temperature effect
ITMI20021801A1 (it) Prodotti di pomodoro.
ZA974366B (en) Potassium, sodium and tris oxaprozin salt pharmaceutical formulations.
EP1411956B8 (en) Use of oversulfated polysaccharides as inhibitors of hiv
EP2301554A8 (en) Composition for the treatment of osteoarthritis
FR2857026B1 (fr) Produit immunomodulateur obtenu a partir d'une culture de bifidobacterium et compositions le contenant
BR0313613A (pt) Variantes do principal alérgeno phl p 1 de capim-timóteo

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1435976

Country of ref document: EP